Cargando…
Efficacy of mRNA anti-SARS-CoV-2 vaccination and dynamics of humoral immune response in patients with solid tumors: results from the institutional registry of an Italian tertiary cancer center
BACKGROUND: Systemic immunosuppression characterizing cancer patients represents a concern regarding the efficacy of anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination, and real-world evidence is needed to define the efficacy and the dynamics of humoral immune response to...
Autores principales: | Fucà, Giovanni, Lecchi, Mara, Ciniselli, Chiara Maura, Ottini, Arianna, Spagnoletti, Andrea, Mazzeo, Laura, Morelli, Daniele, Frati, Paola, Stroscia, Martina, Ebrahem, Elisabella, Sottotetti, Elisa, Galli, Giulia, D’Elia, Maria Grazia, Lobefaro, Riccardo, Ducceschi, Monika, Di Guardo, Lorenza, Bhoori, Sherrie, Provenzano, Salvatore, Platania, Marco, Niger, Monica, Colombo, Elena, Nichetti, Federico, Duca, Matteo, Rivoltini, Licia, Mortarini, Roberta, Baili, Paolo, Apolone, Giovanni, de Braud, Filippo, Verderio, Paolo, Damian, Silvia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340426/ https://www.ncbi.nlm.nih.gov/pubmed/35923922 http://dx.doi.org/10.1177/17588359221108687 |
Ejemplares similares
-
3Rs Principle and Legislative Decrees to Achieve High Standard of Animal Research
por: Verderio, Paolo, et al.
Publicado: (2023) -
COVID-19 Vaccination in Health Care Workers in Italy: A Literature Review and a Report from a Comprehensive Cancer Center
por: Ciniselli, Chiara Maura, et al.
Publicado: (2022) -
Case Report: Prolonged clinical benefit with sequential trastuzumab-containing treatments in a patient with advanced extramammary Paget disease of the groin
por: Zattarin, Emma, et al.
Publicado: (2022) -
Cancer-related fatigue and depression: a monocentric, prospective, cross-sectional study in advanced solid tumors
por: Lobefaro, R., et al.
Publicado: (2022) -
Prognostic impact of body mass index (BMI) in HER2+ breast cancer treated with anti-HER2 therapies: from preclinical rationale to clinical implications
por: Ligorio, Francesca, et al.
Publicado: (2022)